FabOvar

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFabOvar

Drug Alias NameAlpha-Folate Receptor-Targeting I131-Labeled mAb Fragment (Advanced Accelerator Applications)Alpha-Folate Receptor-Targeting I131-Labeled mAb Fragment (Dompe)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionFolate receptor alpha antagonists

TargetsFolate receptor alpha

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDompé Pharmaceutici Spa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAdvanced Accelerator Applications Sa

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A